Shadjalilova Mukarram

2 ta ish

Tashkent Pediatric Medical Institute

1. Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims

   Jasur Rizaev, Z.K. Rakhimov, Shadjalilova Mukarram +4

   Maqola20260 iqtibos

   ABIABI:AkademIndex/2026.article.038450

2. Optimizing Systemic Pharmacological Therapy in Inflammatory Arthritis: Implications for the Temporomandibular Joint and Emerging Molecular Targets—A Systematic Review

   Ranokhon A. Jalolova, Boymuradov, Shukhrat Abdujalilovich, Shadjalilova Mukarram +3

   Sharh maqola20260 iqtibos

   ABIABI:AkademIndex/2026.review-article.000183